Efficacy and safety in adequate regimen of anti-vascular endothelial growth factor (VEGF) therapy for patients with diabetic macular edema
Not Applicable
Recruiting
- Conditions
- diabetic macular edema
- Registration Number
- JPRN-UMIN000020753
- Lead Sponsor
- Shiga University of Medical Science
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Not provided
Exclusion Criteria
Anti-VEGF therapy within the prior 3 months. Retinal photocoagulation within the prior 3 months. Steroid therapy within the prior 3 months. Major ocular surgery within the prior 3 months. A myocardial infarction or other cardiac event requiring hospitalization. cerebrovascular accident, transient ischemic attack, or acute congestive heart failure.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method